From the Research
Nigella sativa Formula for HIV Patients
- The formula used with Human Immunodeficiency Virus (HIV) patients for Nigella sativa is not explicitly stated in the provided studies as a specific formula, but rather as a concoction or oil extract.
- According to the study 1, the patient was commenced on Nigella sativa concoction 10 mls twice daily for 6 months, which led to significant improvements in their condition, including sero-reversion.
- The exact composition of the Nigella sativa concoction used in this study is not specified, but it is known to contain various phytochemical compounds, including thymoquinone, which is considered to be the major bioactive component responsible for its therapeutic effects 2.
- Other studies have investigated the therapeutic potential of Nigella sativa in various conditions, including its antioxidant, anti-inflammatory, and immunomodulatory effects 3, 2, but the specific formula used for HIV patients is not consistently reported.
Dosage and Administration
- The study 1 used a dosage of 10 mls of Nigella sativa concoction twice daily for 6 months.
- Another study 4 used capsules containing Nigella sativa seeds in doses of 1,2, and 3 gm/day for three months to assess its effect on glycemic control in patients with type 2 diabetes mellitus.
- The optimal dosage and administration of Nigella sativa for HIV patients is not established and may require further research to determine the most effective and safe regimen 3.